Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EMA Consults On Managing Serious Breaches Under EU Clinical Trials Regulation

Executive Summary

The European Medicines Agency has issued a draft guideline that explains how drug sponsors should report serious breaches under the upcoming EU Clinical Trials Regulation. The guideline contains a non-exhaustive list of what may or may not qualify as a serious breach.

You may also be interested in...

EU Inspectors Find More Than 1,000 Clinical Trial Deficiencies

The number of deficiencies found by EU GCP inspectors rose to 1,033 in 2016, compared with 912 in 2015, although the number of problematic findings considered “critical” was down slightly. Meanwhile, Japan has asked to join the EMA/FDA initiative on GCP inspections.

UK To Use COVID-19 Learnings To Speed Up Review Of Other Trials

A new pre-assessment service for COVID-19 clinical trials that was established by the UK medicines regulator to cut down on review times is being extended to a limited number of other kinds of trials.

EMA Aims For Better Info On Benefit-Risk Balance To Support Drug Choices In Pregnancy

The European Medicines Agency is developing a strategy to ensure that women have sufficient information to make informed choices about taking medicines during pregnancy and breastfeeding.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts